VT
CRL icon

Vise Technologies’s Charles River Laboratories CRL Stock Holding History

Vise Technologies’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$297K Hold
1,491
– – 0.01% 1141
2025
Q4 		$297K Buy
+1,491
New +$270K 0.01% 1148

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vise Technologies's CRL Position: Q1 2026 in Review

Vise Technologies held its Charles River Laboratories (CRL) position steady in Q1 2026 at 1,491 shares worth $297K. The position accounts for 0.01% of the portfolio, ranked #1141.

Vise Technologies first reported a position in CRL in Q4 2025 and has held it in 2 quarters since. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Vise Technologies held 1,491 shares of Charles River Laboratories worth $297K as of Q1 2026.
  • Vise Technologies left its Charles River Laboratories share count unchanged in Q1 2026.
  • Charles River Laboratories made up 0.01% of Vise Technologies's portfolio in Q1 2026, its #1141 holding.
  • Vise Technologies first reported a position in Charles River Laboratories in Q4 2025 and has held it in 2 quarters since.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.